Re-designation of CGHD as a WHO Collaborating Center
The Center for Global Health & Development has been a World Health Organization Collaborating Centre (WHO CC) in Pharmaceutical Policy since 2000. The Center recently applied for re-designation, proposing a plan for collaboration with WHO Headquarters in Geneva, the PAHO regional office in Washington, and other WHO Collaborating Centers. The re-designation was awarded through 2018.
The proposed key areas of the work are:
1. Good governance for medicines at global and country level;
2. New methods for monitoring and evaluating pharmaceutical policies and programs with focus on low and middle income countries;
3. Advocacy of WHO EML concept and of the rationale and process for updating it.
Veronika Wirtz currently serves as the Director of the Collaborating Center. Please feel free to reach out to Veronika if you have interest in participating in the work that is done in this area.
